Vancomycin Dosing Considerations in a Real‐World Cohort of Obese and Extremely Obese Patients

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 277-0008, Iss. 9, 2015-09 ,pp. : 869-875

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus

By Antony Suresh  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 4, 2006-04 ,pp. : 293-295

Informa Healthcare

Access to resources Recommend Favorite

Synercid plus vancomycin for the Treatment of Severe Methicillin-resistant Staphylococcus aureus and Coagulase-negative Staphylococci Infections: Evaluation of 5 Cases

By Sgarabotto Dino   Cusinato Riccardo   Narne Elena   Scano Fabio   Zignol Matteo   Gambino Antonio   Cattelan Annamaria   Meneghetti Francesco   Cadrobbi Paolo  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 2, 2002-02 ,pp. : 122-126

Informa Healthcare

Access to resources Recommend Favorite

The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia

By Siegman-Igra Yardena   Reich Prachia   Orni-Wasserlauf Ruth   Schwartz David   Giladi Michael  

Scandinavian Journal of Infectious Diseases, Vol. 37, Iss. 8, 2005-08 ,pp. : 572-578

Informa Healthcare

Access to resources Recommend Favorite

Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta‐analysis of Observational Studies

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 10, 2015-10 ,pp. : 889-898

John Wiley & Sons Inc

Access to resources Recommend Favorite